M. Lagrange et al., NONSPECIFICALLY LABELED CELLS THAT SIMULATE BONE-MARROW METASTASES INPATIENTS WITH NONMETASTATIC BREAST-CANCER, Journal of Clinical Pathology, 50(3), 1997, pp. 206-211
Aims-To determine whether the presence of disseminated bone marrow tum
our cells at diagnosis is a prognostic factor for breast cancer patien
ts at high risk of recurrence or bone metastasis, and to assess their
presence as a criterion for evaluation of the potential benefits of ad
juvant chemotherapy. Methods-Multiple bone marrow aspirates from 72 br
east cancer patients free from metastasis were obtained during surgery
at the time of diagnosis and were tested immunologically by alkaline
phosphatase antialkaline phosphatase technique with a panel of three a
ntiepithelial monoclonal antibodies (MoAb) KL(1), EMA, and HMFG(2). Re
sults-In nine of 72 patients, with each MoAb tested, numerous strongly
positive cells always isolated were observed. However, it was demonst
rated that these cells were non-specifically labelled and could be fou
nd in normal controls.Conclusions-There was no evidence of marrow tumo
ur cells in 72 operable breast cancer patients. It is suggested that p
ublished results may be greatly overestimated and that non-specific la
belling may be undetected. More specific MoAb should be found and a co
rrelation with molecular biology should be performed if this criterion
is to be considered as a prognostic factor.